Provided by Tiger Trade Technology Pte. Ltd.

ADC Therapeutics SA

1.05
+0.01000.96%
Post-market: 1.050.00000.00%16:38 EDT
Volume:1.95M
Turnover:2.05M
Market Cap:133.40M
PE:-1.58
High:1.08
Open:1.04
Low:1.01
Close:1.04
52wk High:4.98
52wk Low:0.7796
Shares:127.04M
Float Shares:88.56M
Volume Ratio:0.98
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6636
EPS(LYR):-1.1224
ROE:-705.53%
ROA:-19.57%
PB:-0.58
PE(LYR):-0.94

Loading ...

Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 13, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026

Major Issues Report

Form 8-K - Current report
Jul 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 02, 2026

Major Issues Report

Form 8-K - Current report
Jun 24, 2026

Major Issues Report

Form 8-K - Current report
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
Jun 02, 2026

Major Issues Report

Form 8-K - Current report
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 06, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 13, 2026

Correspondence

Form CORRESP - Correspondence
Mar 11, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2026

Major Issues Report

Form 8-K - Current report
Feb 23, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 10, 2025

Correspondence

Form CORRESP - Correspondence